智慧樹 WT 深 滬
等待開盤 05-06 09:30:00 美东时间
18.15
+0.870
+5.03%
華盛通- 最 高18.24
- 今 開17.63
- 成交量 216.34万股
- 最 低 17.58
- 昨 收 17.28
- 總市值 25.70亿
- 52周最高 18.78
- 市盈率 靜 24.27
- 換手率 1.53%
- 52周最低 9.15
- 委 比 -19.28%
- 總股本 1.42亿
- 歷史最高 24.19
- 量 比 0.78
- 振 幅 3.82%
- 歷史最低 1.15
- 每 手 1
- 風險率 2.28%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多财报速睇 | 智慧树 2026财年Q1营收1.59亿美元，同比增长47.5%；归母净利润亏损0.23亿美元，由盈转亏
华盛资讯5月2日讯，智慧树公布2026财年Q1业绩，公司Q1营收1.59亿美元，同比增长47.5%，归母净利润亏损0.23亿美元，由盈转亏。
05-02 00:20
Transcript: WisdomTree Q1 2026 Earnings Conference Call
WisdomTree (NYSE:WT) released first-quarter financial results and hosted an ear...
05-01 23:53
Earnings Scheduled For May 1, 2026
Companies Reporting Before The Bell • WisdomTree (NYSE:WT) is projected to repo...
05-01 19:11
美股大行评级 | 瑞银：维持Visa"买入"评级！目标价从390美元升至410美元
今日重点评级关注：HC Wainwright & Co.：维持Protara Therapeutics"买入"评级，目标价从23美元升至27美元；BTIG：维持Black Diamond Therapeutic"买入"评级，目标价从10美元升至11美元
04-30 19:24
Oppenheimer Maintains Outperform on WisdomTree, Raises Price Target to $21
Oppenheimer analyst Chris Kotowski maintains WisdomTree (NYSE:WT) with a Outperform and raises the price target from $20 to $21.
04-30 00:57
Shares of financial services companies are trading higher after President Trump's social media post indicated that the U.S. will work closely with Iran, and the countries have already agreed to several key points in the proposed conflict-resolution plan. The sector is also benefiting from easing energy prices and lower Treasury yields, which are helping to alleviate inflation concerns and support overall market sentiment.
Shares of financial services companies are trading higher after President Trump...
04-09 01:37
美股大行评级 | 绩后爆锤！耐克遭10家大行集体下调目标价；NCNO、RH、艾默生电气等也遭大行下调目标价
今日重点评级关注：Canaccord Genuity：维持Generac控股"买入"评级，目标价从275美元升至300美元；Oppenheimer：维持Biogen"跑赢大市"评级，目标价从250美元升至275美元
04-02 16:17
期权扫描 | 一看跌期权大涨4642%，Meta期权成交激增2.4倍；短线投机失败？特斯拉一巨量看涨期权腰斩
一看跌期权大涨4642%，Meta期权成交激增2.4倍；短线投机失败？特斯拉一巨量看涨期权腰斩；看涨期权占比攀升至75%，亚马逊获小摩上调目标价>>
03-27 19:47
美股大行评级 | 大摩、高盛上调Denali Therapeutics目标价；Chewy、沛齐遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Atossa Therapeutics"买入"评级，目标价从7美元升至25美元；Needham：维持Nkarta"买入"评级，目标价从10美元升至11美元
03-27 10:22
Oppenheimer Maintains Outperform on WisdomTree, Lowers Price Target to $20
Oppenheimer analyst Chris Kotowski maintains WisdomTree (NYSE:WT) with a Outperform and lowers the price target from $21 to $20.
03-27 01:53
